Abstract:BACKGROUND & OBJECTIVE:Present chemotherapy for hepatocellular carcinoma (HCC) is not effective. To improve the effect of chemotherapy, in vitro chemo-drug sensitive testing system, adenosine triphosphate tumor chemosensitive assay (ATP-TCA) system, was used to evaluate efficacies of chemotherapeutic drugs, and to guide clinical individual chemotherapy for HCC patients.METHODS:ATP-TCA system was applied to test efficacies of 5-fluorouracil (5-FU), mitomycin (MMC), cisplatin (DDP), oxaliplatin (OXA), epirubicin (EPI), gemcitabine (GEM), irinotecan (CPT-11), etoposide (VP-16), and paclitaxel (PTX) on 50 HCC samples. Twenty-three HCC patients received ATP-TCA-directed chemotherapy (ATP-TCA group)û 20 HCC patients received surgery and routine treatments (control group). Clinical outcomes of these patients were observed for 162 weeks.RESULTS:The assessable rate of ATP-TCA result is 90.8%. In the 50 samples, the sensitive (moderate to high degree) rates were 46% to PTX, 44% to CPT-11, 36% to GEM, 14% to MMC, 12% to EPI, 8% to DDP, 6% to VP-16, 6% to OXA, and 4% to 5-FU, respectively. In clinical trial, at the research end-point, no significant differences were found in partial remission (PR), complete remission (CR), stable disease (SD), and mortality between ATP-TCA group and control group (P > 0.05), but progression disease (PD) rate was significantly higher in control group than in ATP-TCA group (60.00% vs.13.04%, P=0.003); significant differences were found in overall response rate (ORR) (60.86% vs. 30.00%, P =0.043), overall survival (OS) (78.91 weeks vs. 27.21 weeks, P=0.006), and progress-free survival (PFS) (30.52 weeks vs. 4.78 weeks, P=0.005) between ATP-TCA group and control group.CONCLUSIONS:ATP-TCA system might be useful in evaluating the efficacy of chemotherapeutic drugs on HCC samples, and in planning individualized chemotherapy regimen for HCC patients. PTX, CPT-11 and GEM might be potential drugs for the treatment of HCC. ATP-TCA-guided chemotherapy might prolong survival time of HCC patients.

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

A Retrospective Study of the Correlation of in Vitro Chemosensitivity Using ATP-TCA with Patient Clinical Outcomes in Acute Myeloid Leukemia

Application of in Vitro ATP Tumor Chemosensitivity Assay and Flow Cytometry in the Chemotherapy of Gastrointestinal Carcinoma

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Study on the chemosensitivity test with TECIA in vitro for the choice of individualized chemotherapy of lung cancer

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

[Sensitivity of Two Cell Lines with Acquired Resistance to Gefitinib to Several Chemotherapeutic Drugs].

[Application of Adenosine Triphosphate Tumor Chemosensitive Assay System to Individual Chemotherapy for Hepatocellular Carcinoma].

Correlation Between ATP Bioluminescence Tumor Chemosensitivity Assay and Clinical Response in Ovarian Cancer

Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy

Mutational Landscape of Cfdna Identifies Distinct Molecular Features Associated with Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.

The Chemotherapy Sensitivity and Gene Expression in Lung Cancer Cell Lines

The Application of the Ex Vitro Adenosine Triphosphate Tumor Chemosensitivity Assay in the Chemotherapy of Primary Live Cancer

Application of in Vitro ATP-TCA and FCM in Chemotherapy of Primary Liver Cancer

In Vitro Chemosensitivity Testing of Primary and Recurrent Breast Carcinomas and Its Clinical Significance

Application of ATP-TCA in Post-Operative Chemotherapy of Hepatocellular Carcinoma

[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer]

P1.03-046 A Retrospective Analysis of Correlation Between Cytokines in TME and Therapeutic Effect of Advanced Lung Cancer Chemotherapy in China

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

Application of an ATP-Bioluminescence Assay in Ovarian Cancer Chemosensitivity Testing in Vitro